GW PHARMACEUTICALS PLC Contracts & Agreements
22 Contracts & Agreements
- Business Finance (1 contract)
- Human Resources (10)
- Uncategorized (11)
- Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 26, 2021)
- Offer Letter, dated February 25, 2021 between Greenwich Biosciences, Inc. and Justin Gover (Filed With SEC on February 26, 2021)
- Letter of Appointment by and between GW Pharmaceuticals plc and Justin Gover, dated February 25, 2021 (Filed With SEC on February 26, 2021)
- Transition Incentive Bonus Letter dated February 25, 2021, by and between Greenwich Biosciences. Inc. and Justin Gover (Filed With SEC on February 26, 2021)
- Form of Transition Incentive Bonus Letter (non-CEO) (Filed With SEC on February 26, 2021)
- Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan (Filed With SEC on February 26, 2021)
- GW UK Change in Control and Severance Benefit Plan (GW Pharma Limited / GW Research Limited) (Filed With SEC on February 26, 2021)
- Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement, dated February 25, 20201, between Greenwich Biosciences,... (Filed With SEC on February 26, 2021)
- Change in Control and Severance Benefit Plan Participation Agreement, dated February 25, 2021, by and between GW Pharmaceuticals plc and Geoffrey Guy (Filed With SEC on February 26, 2021)
- Form of Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement for Existing EVP Participation (Filed With SEC on February 26, 2021)
- Form of Greenwich Biosciences, Inc. Amended and Restated Change in Control and Severance Benefit Plan Participation Agreement for EVP Participation (Filed With SEC on February 26, 2021)
- Form of GW UK Change in Control and Severance Benefit Plan Participation Agreement (Filed With SEC on February 26, 2021)
- Transaction Agreement, dated as of February 3, 2021, by and among GW Pharmaceuticals plc, Jazz Pharmaceuticals UK Holdings Limited and Jazz Pharmaceuticals Public Limited Company (Filed With SEC on February 3, 2021)
- Letter of Appointment by and between GW Pharmaceuticals plc and David Gryska, dated September 9, 2020 (Filed With SEC on November 5, 2020)
- Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2020)
- PRV Transfer Agreement, dated March 15, 2019, by and between GW Research Ltd. and Biohaven Pharmaceutical Holding Ltd (Filed With SEC on May 8, 2019)
- Offer letter by and between Greenwich Biosciences, Inc. and Darren Cline (Filed With SEC on April 12, 2019)
- Severance Agreement dated April 12, 2019 by and between Greenwich Biosciences, Inc. and Julian Gangolli (Filed With SEC on April 12, 2019)
- Letter of Appointment by and between GW Pharmaceuticals plc and Catherine Mackey, dated December 20, 2017 (Filed With SEC on November 29, 2018)
- Letter of Appointment by and between GW Pharmaceuticals plc and Alicia Secor, dated December 20, 2017 (Filed With SEC on November 29, 2018)
- Letter of Appointment by and between GW Pharmaceuticals plc and Lord William Waldegrave, dated December 20, 2017 (Filed With SEC on November 29, 2018)
- Underwriting Agreement, dated October 2, 2018, by and between GW Pharmaceuticals plc and Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC, as... (Filed With SEC on October 5, 2018)
